Health Subcommittee, Energy and Commerce Committee
Introduced
In Committee
On Floor
Passed Chamber
Enacted
Market Access for Generic Insulin Competition or the MAGIC Act This bill provides a pathway for the Food and Drug Administration to approve chemically synthesized insulin or an analogue of chemically synthesized insulin as a generic drug under the abbreviated new drug application process.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Health
Competition and antitrustDigestive and metabolic diseasesDrug safety, medical device, and laboratory regulationLicensing and registrationsManufacturingPrescription drugs
MAGIC Act
USA116th CongressHR-4244| House
| Updated: 9/10/2019
Market Access for Generic Insulin Competition or the MAGIC Act This bill provides a pathway for the Food and Drug Administration to approve chemically synthesized insulin or an analogue of chemically synthesized insulin as a generic drug under the abbreviated new drug application process.
Health Subcommittee, Energy and Commerce Committee
Health
Introduced
In Committee
On Floor
Passed Chamber
Enacted
Competition and antitrustDigestive and metabolic diseasesDrug safety, medical device, and laboratory regulationLicensing and registrationsManufacturingPrescription drugs